| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.11B | -7.6% |
| Cost of Revenue | $702.1M | -4.7% |
| Gross Profit | $404.0M | -12.3% |
| R&D Expense | $500K | -91.7% |
| SG&A Expense | $141.8M | +1.6% |
| Operating Income | $246.7M | -10.4% |
| Pre-tax Income | $246.8M | -10.4% |
| Income Tax | $62.2M | -6.7% |
| Net Income | $184.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.3M | -91.3% |
| Accounts Receivable | $98.1M | -35.1% |
| Inventory | $141.4M | +68.8% |
| Current Assets | $286.8M | -28.5% |
| Total Assets | $933.7M | +1.5% |
| Current Liabilities | $290.6M | +227.6% |
| Total Liabilities | $415.4M | +112.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $216.2M | -16.2% |
| Capital Expenditures | $176.2M | +10.6% |
| Investing Cash Flow | -$168.9M | -6.9% |
| Financing Cash Flow | -$176.1M | -118.2% |
| Free Cash Flow | $40.0M | -59.5% |
| -11.6% |
| EPS (Basic) | $1.65 | -8.8% |
| EPS (Diluted) | $1.65 | -8.3% |
| Stockholders' Equity |
| $518.3M |
| -28.5% |